Pfizer posts 30% rise in quarterly profit
Pfizer Inc on Monday reported a 30% rise in quarterly profit, helped by demand for its branded treatments such as Ibrance, Eliquis and Xeljanz.
Pfizer Inc on Monday reported a 30% rise in quarterly profit, helped by demand for its branded treatments such as Ibrance, Eliquis and Xeljanz.
Mylan NV confirmed on Monday that it would combine with Pfizer Inc's off-patent branded and generic established medicines business to form a global generic drugmaker.
U.S. stock markets were set to open just off record highs on Monday, pausing at the start of a week set to be dominated by Wednesday's statement by the Federal Reserve and a round of tech company earnings that will again test the impact of trade concerns on global growth.
Here are the biggest calls on Wall Street on Monday
Goldman Sachs initiated coverage of Chipotle with a buy rating and a $1,000 price target.
Amazon.com Inc is planning a foray into the burgeoning online food delivery business in India this year, two sources aware of the development said, in a move that could raise competition in an increasingly crowded market.
New Companies for Week Ending 7/21/2019
The post New Companies for Week Ending 7/28/2019 appeared first on Crowditz.
Funding Report for Week Ending 7/28/2019
The post Funding Report for Week Ending 7/28/2019 appeared first on Crowditz.
Global shares steadied on Monday and the dollar hit a two-month high against a basket of currencies as markets counted down to a likely cut in U.S. interest rates this week, with much riding on whether the Federal Reserve signals more cuts will follow.
Drugmaker Pfizer Inc has agreed to spin off its generic drugs business and combine it with Mylan , a move that leaves Pfizer with more profitable innovative drugs, including cancer drug Ibrance and pneumonia vaccine Prevnar.
Wall Street's main indexes opened below their record highs on Monday, in a muted start to a week likely to be dominated by the Federal Reserve's policy stance and a round of tech company earnings that will again test the impact of trade concerns on global growth.
U.S. stocks slid on Monday as technology shares fell in the run up to earnings from tech companies, which will test the impact of trade tensions on global growth, and ahead of the Federal Reserve's policy-setting meeting.
Morgan Stanley is using big data to help clients identify their sustainable investing choices and measure how well their portfolios track those goals.
Exact Sciences Corp said on Monday it will buy peer Genomic Health Inc for about $2.8 billion in cash and stock, expanding the cancer diagnostic company's testing capabilities to breast and prostate cancers.
Oil prices rose on Monday as the prospect of an expected interest rate cut by the U.S. Federal Reserve overshadowed pessimism over U.S.-China trade talks and oil demand fears stoked by forecasts for slower global economic growth.